Eisai
4523.T
$34.08
Share price
6.11%
Change (1 day)
-37.22%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Eisai (4523.T) - Total debt
Total debt on the balance sheet as of March 2024 : S$1.40 Billion
According to Eisai's latest financial reports the company's total debt is S$1.40 Billion. A company’s total debt is the sum of all current and non-current debts.
Eisai - Total debt on balance sheet (from 2009 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | S$1.42 B | 12.99% |
| 2023-03-31 | S$1.25 B | 19.52% |
| 2022-03-31 | S$1.05 B | -4.19% |
| 2021-03-31 | S$1.09 B | -7.38% |
| 2020-03-31 | S$1.18 B | -30.11% |
| 2019-03-31 | S$1.69 B | -20.53% |
| 2018-03-31 | S$2.13 B | -20.02% |
| 2017-03-31 | S$2.66 B | 9% |
| 2016-03-31 | S$2.44 B | -9.54% |
| 2015-03-31 | S$2.70 B | -10.56% |
| 2014-03-31 | S$3.02 B | -26.77% |
| 2013-03-31 | S$4.13 B | -21.09% |
| 2012-03-31 | S$5.23 B | -9.1% |
| 2011-03-31 | S$5.76 B | -6.04% |
| 2010-03-31 | S$6.13 B | -5.42% |
| 2009-03-31 | S$6.48 B | 13.51% |
| 2008-03-31 | S$5.71 B | 187741.19% |
| 2007-03-31 | S$3.04 M | -46.34% |
| 2006-03-31 | S$5.66 M | -55.89% |
| 2005-03-31 | S$12.84 M | 318.59% |
| 2004-03-31 | S$3.06 M | 485.92% |
| 2003-03-31 | S$0.52 M | -99.42% |
| 2002-03-31 | S$90.53 M | -20.22% |
| 2001-03-31 | S$0.11 B | -62.38% |
| 2000-03-31 | S$0.30 B |